Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC (CNB-CSIC), Campus-UAM, Madrid, Spain.
The Francis Crick Institute, London, United Kingdom.
Elife. 2023 Jul 17;12:e86200. doi: 10.7554/eLife.86200.
Evidence implicating p38γ and p38δ (p38γ/p38δ) in inflammation are mainly based on experiments using -deficient (p38γ/δKO) mice, which show low levels of TPL2, the kinase upstream of MKK1-ERK1/2 in myeloid cells. This could obscure p38γ/p38δ roles, since TPL2 is essential for regulating inflammation. Here, we generated a / (p38γ/δKIKO) mouse, expressing kinase-inactive p38γ and lacking p38δ. This mouse exhibited normal TPL2 levels, making it an excellent tool to elucidate specific p38γ/p38δ functions. p38γ/δKIKO mice showed a reduced inflammatory response and less susceptibility to lipopolysaccharide (LPS)-induced septic shock and infection than wild-type (WT) mice. Gene expression analyses in LPS-activated wild-type and p38γ/δKIKO macrophages revealed that p38γ/p38δ-regulated numerous genes implicated in innate immune response. Additionally, phospho-proteomic analyses and in vitro kinase assays showed that the transcription factor myocyte enhancer factor-2D (MEF2D) was phosphorylated at Ser444 via p38γ/p38δ. Mutation of MEF2D Ser444 to the non-phosphorylatable residue Ala increased its transcriptional activity and the expression of and mRNA. These results suggest that p38γ/p38δ govern innate immune responses by regulating MEF2D phosphorylation and transcriptional activity.
涉及 p38γ 和 p38δ(p38γ/p38δ)在炎症中的证据主要基于使用缺乏 p38γ/δ(p38γ/δKO)小鼠的实验,这些小鼠在髓样细胞中 TPL2(MKK1-ERK1/2 的上游激酶)的水平较低。这可能会掩盖 p38γ/p38δ 的作用,因为 TPL2 对于调节炎症是必不可少的。在这里,我们生成了一个 /(p38γ/δKIKO)小鼠,表达激酶失活的 p38γ 且缺乏 p38δ。这种小鼠表现出正常的 TPL2 水平,使其成为阐明特定 p38γ/p38δ 功能的绝佳工具。与野生型(WT)小鼠相比,p38γ/δKIKO 小鼠表现出炎症反应降低,对脂多糖(LPS)诱导的败血症休克和感染的敏感性降低。在 LPS 激活的野生型和 p38γ/δKIKO 巨噬细胞中的基因表达分析表明,p38γ/p38δ 调节了许多参与先天免疫反应的基因。此外,磷酸化蛋白质组学分析和体外激酶测定表明,转录因子肌细胞增强因子 2D(MEF2D)通过 p38γ/p38δ 在 Ser444 处被磷酸化。将 MEF2D Ser444 突变为非磷酸化残基 Ala 增加了其转录活性和 和 mRNA 的表达。这些结果表明,p38γ/p38δ 通过调节 MEF2D 磷酸化和转录活性来控制先天免疫反应。